Combination of Atezolizumab, Bevacizumab, and Chemotherapy (IMpower 150) in a Patient With NSCLC Having Leptomeningeal Metastases

Detalles Bibliográficos
Autores principales: Remon, Jordi, Castro-Henriques, María, Esteller, Laura, Vives, Josep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474250/
https://www.ncbi.nlm.nih.gov/pubmed/34589968
http://dx.doi.org/10.1016/j.jtocrr.2020.100096
_version_ 1784575170961211392
author Remon, Jordi
Castro-Henriques, María
Esteller, Laura
Vives, Josep
author_facet Remon, Jordi
Castro-Henriques, María
Esteller, Laura
Vives, Josep
author_sort Remon, Jordi
collection PubMed
description
format Online
Article
Text
id pubmed-8474250
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84742502021-09-28 Combination of Atezolizumab, Bevacizumab, and Chemotherapy (IMpower 150) in a Patient With NSCLC Having Leptomeningeal Metastases Remon, Jordi Castro-Henriques, María Esteller, Laura Vives, Josep JTO Clin Res Rep Case Report Elsevier 2020-09-12 /pmc/articles/PMC8474250/ /pubmed/34589968 http://dx.doi.org/10.1016/j.jtocrr.2020.100096 Text en © 2020 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Remon, Jordi
Castro-Henriques, María
Esteller, Laura
Vives, Josep
Combination of Atezolizumab, Bevacizumab, and Chemotherapy (IMpower 150) in a Patient With NSCLC Having Leptomeningeal Metastases
title Combination of Atezolizumab, Bevacizumab, and Chemotherapy (IMpower 150) in a Patient With NSCLC Having Leptomeningeal Metastases
title_full Combination of Atezolizumab, Bevacizumab, and Chemotherapy (IMpower 150) in a Patient With NSCLC Having Leptomeningeal Metastases
title_fullStr Combination of Atezolizumab, Bevacizumab, and Chemotherapy (IMpower 150) in a Patient With NSCLC Having Leptomeningeal Metastases
title_full_unstemmed Combination of Atezolizumab, Bevacizumab, and Chemotherapy (IMpower 150) in a Patient With NSCLC Having Leptomeningeal Metastases
title_short Combination of Atezolizumab, Bevacizumab, and Chemotherapy (IMpower 150) in a Patient With NSCLC Having Leptomeningeal Metastases
title_sort combination of atezolizumab, bevacizumab, and chemotherapy (impower 150) in a patient with nsclc having leptomeningeal metastases
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474250/
https://www.ncbi.nlm.nih.gov/pubmed/34589968
http://dx.doi.org/10.1016/j.jtocrr.2020.100096
work_keys_str_mv AT remonjordi combinationofatezolizumabbevacizumabandchemotherapyimpower150inapatientwithnsclchavingleptomeningealmetastases
AT castrohenriquesmaria combinationofatezolizumabbevacizumabandchemotherapyimpower150inapatientwithnsclchavingleptomeningealmetastases
AT estellerlaura combinationofatezolizumabbevacizumabandchemotherapyimpower150inapatientwithnsclchavingleptomeningealmetastases
AT vivesjosep combinationofatezolizumabbevacizumabandchemotherapyimpower150inapatientwithnsclchavingleptomeningealmetastases

Ejemplares similares